Press Releases

Press Releases

12.02.19
OpGen Provides Curetis Group Business Update and Announces Completion of Key Milestones in Planned Business Combination
11.19.19
OpGen Products in Development to Address “Urgent Threat” Pathogens Highlighted in New CDC Report on Antibiotic Resistance Threats
11.06.19
OpGen Reports Third Quarter 2019 Financial Results and Provides Business Update
11.04.19
OpGen Provides Update on Curetis Group Company Ares Genetics Business
10.29.19
OpGen Announces Date of Third Quarter 2019 Financial Results Conference Call
10.28.19
OpGen Announces Closing of $9.4 Million Underwritten Public Offering
10.23.19
OpGen Announces Pricing of $9.4 Million Underwritten Offering
10.23.19
U.S. Patent Allowed Covering Acuitas Lighthouse® Software
10.07.19
OpGen Presents Preliminary Acuitas® AMR Gene Panel Data for Detecting Urinary Tract Infections
09.26.19
OpGen to Present on Guiding Precision Antibiotic Therapy with Rapid Genomics and Informatics at IDWeek 2019